Our R & D team analyzed that the mutation site of the N protein of b.1.1.529 mutant virus (generally called Omicron) did not fall in the epitope region of Lomina’s set of monoclonal antibody, so the mutation has no impact in the detection capability of Lomina Antigen tests.

The recognition sites of antibody used in Lomina tests have been located in the n47-a173 region at the N-terminal of nucleoprotein.

The Omicron strain has mutatin sites on NP protein of P13L, Δ 31-33, r203k and g204r, so our products are not affected by the mutation.